What is it about?

This paper delineates different estimands of a comparative clinical trial

Featured Image

Why is it important?

An "estimand" is "what question the analysis aims to address", hence it is the foremost important subject for a clinical trial.

Perspectives

This commentary on the FDA's papers further clarifies the issue of estimands and sensitivity analysis.

Weichung Shih

Read the Original

This page is a summary of: Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem, Statistics in Medicine, July 2016, Wiley,
DOI: 10.1002/sim.6895.
You can read the full text:

Read

Contributors

The following have contributed to this page